Barriers to better care for people with AIDS in developing countries

WHO's “3 by 5” initiative to increase access to antiretroviral drugs to people with AIDS in developing countries is highly ambitious. Some of the biggest obstacles relate to delivering care

Saved in:
Bibliographic Details
Published inBMJ Vol. 329; no. 7477; pp. 1281 - 1283
Main Authors Furber, Andrew S, Hodgson, Ian J, Desclaux, Alice, Mukasa, David S
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 27.11.2004
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group
BMJ Publishing Group Ltd
EditionInternational edition
Subjects
Acquired immune deficiency syndrome
Acquired Immunodeficiency Syndrome - drug therapy
AIDS
Anti-HIV Agents - supply & distribution
Antiretrovirals
Antivirals
Biological and medical sciences
Community action
Confidentiality
Continuity of Patient Care
Delivery of Health Care - standards
Developed countries
Developing Countries
Drug therapy
Education And Debate
General aspects
Health care access
Health care delivery
Health care industry
Health care organizations
Health Services Accessibility - organization & administration
HIV
Human immunodeficiency virus
Human viral diseases
Humans
Infectious diseases
Medical sciences
Medical treatment
Prejudice
Public health
Social stigma
Stereotyping
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Infection
Medicine
Immunopathology
Viral disease
Developing countries
AIDS
Barrier
Immune deficiency
Public health
Care
Online AccessGet full text

Cover

More Information
Summary:WHO's “3 by 5” initiative to increase access to antiretroviral drugs to people with AIDS in developing countries is highly ambitious. Some of the biggest obstacles relate to delivering care
Bibliography:PMID:15564262
local:bmj;329/7477/1281
ArticleID:bmj.329.7477.1281
Correspondence to: A S Furber
istex:6B666E3F422564F54863C853964C7C522D35DAEF
ark:/67375/NVC-JB04JTPH-K
href:bmj-329-1281.pdf
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Correspondence to: A S Furber A.Furber@sheffield.ac.uk
References w1-w20 are on bmj.com
Contributors and sources: This article was written after discussion between the authors at recent international AIDS conferences in the light of keynote presentations by WHO/UNAIDS. The authors have experience of working in AIDS programmes in Asia and Africa both in government and non-government sectors. ASF wrote the first draft and is the guarantor. IJH, AD, and DSM all revised and added to parts of the paper.
Competing interests: None declared.
ASF, IJH, and DSM have received support from Health and Development Networks (www.hdnet.org) to report on international AIDS events which have helped inform this article. The views expressed do not necessarily represent the views of organisations for which the authors work. We thank the external reviewers for their helpful comments.
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.329.7477.1281